PL2236598T3 - Drobnoustroje do poprawy stanu zdrowia osobników z zaburzeniami związanymi ze spożyciem glutenu - Google Patents
Drobnoustroje do poprawy stanu zdrowia osobników z zaburzeniami związanymi ze spożyciem glutenuInfo
- Publication number
- PL2236598T3 PL2236598T3 PL08865212T PL08865212T PL2236598T3 PL 2236598 T3 PL2236598 T3 PL 2236598T3 PL 08865212 T PL08865212 T PL 08865212T PL 08865212 T PL08865212 T PL 08865212T PL 2236598 T3 PL2236598 T3 PL 2236598T3
- Authority
- PL
- Poland
- Prior art keywords
- microorganisms
- individuals
- health
- improving
- disorders related
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Transplantation (AREA)
- Pulmonology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200703427A ES2343499B1 (es) | 2007-12-24 | 2007-12-24 | Microorganismos para mejorar el estado de salud de individuos con desordenes relacionados con la ingesta de gluten. |
| PCT/ES2008/070243 WO2009080862A1 (es) | 2007-12-24 | 2008-12-23 | Microorganismos para mejorar el estado de salud de individuos con desordenes relacionados con la ingesta de gluten |
| EP08865212A EP2236598B1 (en) | 2007-12-24 | 2008-12-23 | Microorganisms for improving the health of individuals with disorders related to gluten ingestion |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2236598T3 true PL2236598T3 (pl) | 2013-08-30 |
Family
ID=40800750
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL08865212T PL2236598T3 (pl) | 2007-12-24 | 2008-12-23 | Drobnoustroje do poprawy stanu zdrowia osobników z zaburzeniami związanymi ze spożyciem glutenu |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8501169B2 (pl) |
| EP (1) | EP2236598B1 (pl) |
| JP (1) | JP5693232B2 (pl) |
| KR (1) | KR20100110341A (pl) |
| CN (1) | CN101983237B (pl) |
| AU (1) | AU2008341708B2 (pl) |
| BR (1) | BRPI0819533B1 (pl) |
| CA (1) | CA2710666C (pl) |
| CY (1) | CY1113848T1 (pl) |
| DK (1) | DK2236598T3 (pl) |
| ES (2) | ES2343499B1 (pl) |
| MX (1) | MX2010007038A (pl) |
| PL (1) | PL2236598T3 (pl) |
| PT (1) | PT2236598E (pl) |
| SI (1) | SI2236598T1 (pl) |
| WO (1) | WO2009080862A1 (pl) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110081320A1 (en) * | 2009-10-06 | 2011-04-07 | Nubiome, Inc. | Treatment/Cure of Autoimmune Disease |
| US20140187474A1 (en) * | 2011-02-16 | 2014-07-03 | The Board Of Trustees Of The Leland Stanford Junior University | Therapeutic use of mucin glycans |
| GB201117313D0 (en) | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
| WO2013130773A2 (en) | 2012-02-29 | 2013-09-06 | Ethicon Endo-Surgery, Inc. | Compositions of microbiota and methods related thereto |
| GB201306536D0 (en) | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
| FI127483B (en) | 2014-06-11 | 2018-07-13 | Gut Guide Oy | Microbial marker for celiac disease and related product |
| CA2964480A1 (en) | 2014-10-31 | 2016-05-06 | Whole Biome Inc. | Methods and compositions relating to microbial treatment and diagnosis of disorders |
| US11116805B2 (en) | 2014-11-19 | 2021-09-14 | Kabushiki Kaisha Yakult Honsha | Preventive and therapeutic agent for celiac disease |
| PL3065748T3 (pl) | 2014-12-23 | 2018-07-31 | 4D Pharma Research Limited | Szczep Bacteroides thetaiotaomicron i jego zastosowanie w zmniejszaniu zapalenia |
| KR20170091157A (ko) | 2014-12-23 | 2017-08-08 | 4디 파마 리서치 리미티드 | 피린 폴리펩티드 및 면역 조정 |
| ES2575828B1 (es) * | 2014-12-31 | 2017-07-07 | Universidad De León | Empleo de probióticos en el incremento de la fertilidad masculina |
| MA41060B1 (fr) | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
| EA201890050A1 (ru) | 2015-06-15 | 2018-06-29 | 4Д Фарма Рисёрч Лимитед | Композиции, содержащие бактериальные штаммы |
| SI3240554T1 (sl) | 2015-06-15 | 2019-12-31 | 4D Pharma Research Limited, | Blautia stercosis in wexlerae za uporabo v zdravljenju vnetnih in avtoimunskih bolezni |
| MD3650033T2 (ro) | 2015-06-15 | 2022-08-31 | 4D Pharma Res Ltd | Compoziții conţinând tulpini bacteriene |
| MA41010B1 (fr) | 2015-06-15 | 2020-01-31 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
| GB201515557D0 (en) * | 2015-09-02 | 2015-10-14 | 14M Genomics Ltd | Method of sequencing |
| AU2016357554B2 (en) | 2015-11-20 | 2019-04-04 | Cj Bioscience, Inc. | Compositions comprising bacterial strains |
| GB201520497D0 (en) | 2015-11-20 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| GB201612191D0 (en) | 2016-07-13 | 2016-08-24 | 4D Pharma Plc | Compositions comprising bacterial strains |
| EP3520801A1 (en) | 2016-03-04 | 2019-08-07 | 4D Pharma Plc | Compositions comprising bacterial blautia strains for treating visceral hypersensitivity |
| EP3222282A1 (en) * | 2016-03-21 | 2017-09-27 | Bionou Research, S.L. | Use of probiotics in the treatment and/or prevention of psoriasis |
| TW201821093A (zh) | 2016-07-13 | 2018-06-16 | 英商４Ｄ製藥有限公司 | 包含細菌菌株之組合物 |
| EP3272396A1 (en) * | 2016-07-18 | 2018-01-24 | Bionou Research, S.L. | Use of probiotics in the treatment and/or prevention of atopic dermatitis |
| GB201621123D0 (en) | 2016-12-12 | 2017-01-25 | 4D Pharma Plc | Compositions comprising bacterial strains |
| JP2020501570A (ja) * | 2016-12-16 | 2020-01-23 | ヴェダンタ バイオサイエンシーズ インコーポレーテッドＶｅｄａｎｔａ Ｂｉｏｓｃｉｅｎｃｅｓ， Ｉｎｃ． | 細菌完全性を決定するための方法および組成物 |
| JP7212945B2 (ja) | 2017-05-22 | 2023-01-26 | フォーディー ファーマ リサーチ リミテッド | 細菌株を含む組成物 |
| TW201907931A (zh) | 2017-05-24 | 2019-03-01 | 英商4D製藥研究有限公司 | 包含細菌菌株之組合物 |
| MD3804737T2 (ro) | 2017-06-14 | 2022-10-31 | 4D Pharma Res Limited | Compoziții care conțin tulpini bacteriene |
| CN115813955A (zh) | 2017-06-14 | 2023-03-21 | 4D制药研究有限公司 | 包含细菌菌株的组合物 |
| WO2018229188A1 (en) | 2017-06-14 | 2018-12-20 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
| WO2019046646A1 (en) | 2017-08-30 | 2019-03-07 | Whole Biome Inc. | METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS |
| BR112020010929A2 (pt) * | 2017-12-29 | 2020-11-17 | Société des Produits Nestlé S.A. | produção de serpina |
| JP7811843B2 (ja) | 2018-07-19 | 2026-02-06 | ペンデュラム セラピューティクス， インコーポレイテッド | 微生物生着のための方法および組成物 |
| AU2019351019B2 (en) * | 2018-09-27 | 2024-09-19 | Research Development Foundation | Methods and probiotic compositions for the treatment of bone disorders |
| CA3129375A1 (en) * | 2019-02-08 | 2020-08-13 | Mcmaster University | Use of activators of the aryl hydrocarbon receptor for treating gluten-induced gastrointestinal diseases |
| WO2021001367A1 (en) * | 2019-07-01 | 2021-01-07 | Société des Produits Nestlé S.A. | Serpin production |
| WO2021001368A1 (en) * | 2019-07-01 | 2021-01-07 | Société des Produits Nestlé S.A. | Serpin production |
| EP4081052A1 (en) | 2019-12-23 | 2022-11-02 | Evonik Operations GmbH | Bacterial consortium comprising at least one bacillus and lactobacillus strain for gluten degradation |
| CA3162327A1 (en) * | 2019-12-23 | 2021-07-01 | Bodo SPECKMANN | Process to identify consortia of probiotic strains suitable for gluten degradation |
| EP3851115A1 (en) * | 2020-01-15 | 2021-07-21 | Biopolis, S.L. | Probiotic composition for its use as an antioxidant |
| CN112694992B (zh) * | 2020-12-30 | 2023-02-21 | 江南大学 | 一株可缓解腹泻的两歧双歧杆菌及其应用 |
| CN115400154A (zh) * | 2022-08-10 | 2022-11-29 | 深圳未知君生物科技有限公司 | 长双歧杆菌在制备治疗自闭症谱系障碍的药物中的应用 |
| ES3008845A1 (es) | 2023-09-22 | 2025-03-25 | Consejo Superior Investigacion | Proteína degradadora de gluten y usos de la misma |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7285526B2 (en) | 1995-07-14 | 2007-10-23 | Meiogen Biotechnology Corporation | Interferon antagonists useful for the treatment of interferon related diseases |
| ID29150A (id) * | 1999-01-15 | 2001-08-02 | Entpr Ireland Cs | Penggunaan lactobacillus salivarius |
| US6562943B1 (en) | 1999-04-21 | 2003-05-13 | Zycos, Inc. | Peptide epitopes recognized by disease promoting CD4+ T lymphocytes |
| US20030092163A1 (en) * | 2001-07-26 | 2003-05-15 | Collins John Kevin | Probiotic bifidobacterium strains |
| US7320788B2 (en) | 2002-02-14 | 2008-01-22 | The Board Of Trustees Of The Leland Stanford Junior University | Enzyme treatment of foodstuffs for Celiac Sprue |
| ITMI20020399A1 (it) * | 2002-02-28 | 2003-08-28 | Ct Sperimentale Del Latte S P | Composizioni dietetiche e/o farmaceutiche per uso umano e/o animale abase di preparati microbici probiotici |
| US7202216B2 (en) | 2002-05-14 | 2007-04-10 | The Board Of Trustees Of The Leland Stanford Junior University | Drug therapy for celiac sprue |
| WO2004076615A2 (en) * | 2003-02-27 | 2004-09-10 | Bioneer A/S | Immunomodulating probiotic compounds |
| GB0323039D0 (en) * | 2003-10-01 | 2003-11-05 | Danisco | Method |
| US7579313B2 (en) | 2003-11-18 | 2009-08-25 | The Board Of Trustees Of The Leland Stanford Junior University | Transglutaminase inhibitors and methods of use thereof |
| US7563864B2 (en) | 2004-04-26 | 2009-07-21 | Celiac Sprue Research Foundation | Prolyl endopeptidase mediated destruction of T cell epitopes in whole gluten |
| WO2006097949A1 (en) * | 2005-03-16 | 2006-09-21 | Actial Farmacêutica, Lda. | Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough |
| US8071101B2 (en) | 2005-11-03 | 2011-12-06 | Avaxia Biologics, Inc. | Antibody therapy for treatment of diseases associated with gluten intolerance |
| DK1993357T3 (da) | 2006-02-09 | 2014-04-22 | Alba Therapeutics Corp | Formuleringer af en tight junction effektor |
| WO2007108763A1 (en) * | 2006-03-17 | 2007-09-27 | Probac Ab | Use of lactobacillus strains for promoting immunotolerance in autoimmune disease |
-
2007
- 2007-12-24 ES ES200703427A patent/ES2343499B1/es active Active
-
2008
- 2008-12-23 US US12/810,369 patent/US8501169B2/en active Active
- 2008-12-23 PT PT88652128T patent/PT2236598E/pt unknown
- 2008-12-23 EP EP08865212A patent/EP2236598B1/en active Active
- 2008-12-23 JP JP2010540149A patent/JP5693232B2/ja active Active
- 2008-12-23 WO PCT/ES2008/070243 patent/WO2009080862A1/es not_active Ceased
- 2008-12-23 AU AU2008341708A patent/AU2008341708B2/en active Active
- 2008-12-23 CA CA2710666A patent/CA2710666C/en active Active
- 2008-12-23 KR KR1020107016396A patent/KR20100110341A/ko not_active Ceased
- 2008-12-23 SI SI200830918T patent/SI2236598T1/sl unknown
- 2008-12-23 DK DK08865212.8T patent/DK2236598T3/da active
- 2008-12-23 BR BRPI0819533-1A patent/BRPI0819533B1/pt active IP Right Grant
- 2008-12-23 PL PL08865212T patent/PL2236598T3/pl unknown
- 2008-12-23 CN CN2008801274139A patent/CN101983237B/zh active Active
- 2008-12-23 MX MX2010007038A patent/MX2010007038A/es active IP Right Grant
- 2008-12-23 ES ES08865212T patent/ES2402183T3/es active Active
-
2013
- 2013-03-26 CY CY20131100250T patent/CY1113848T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI2236598T1 (sl) | 2013-08-30 |
| CA2710666C (en) | 2018-12-04 |
| MX2010007038A (es) | 2010-10-15 |
| CA2710666A1 (en) | 2009-07-02 |
| JP2011507540A (ja) | 2011-03-10 |
| PT2236598E (pt) | 2013-04-02 |
| AU2008341708A1 (en) | 2009-07-02 |
| CY1113848T1 (el) | 2016-07-27 |
| US20100310520A1 (en) | 2010-12-09 |
| JP5693232B2 (ja) | 2015-04-01 |
| US8501169B2 (en) | 2013-08-06 |
| EP2236598A1 (en) | 2010-10-06 |
| DK2236598T3 (da) | 2013-04-02 |
| KR20100110341A (ko) | 2010-10-12 |
| WO2009080862A1 (es) | 2009-07-02 |
| BRPI0819533A2 (pt) | 2014-10-14 |
| AU2008341708B2 (en) | 2014-07-17 |
| CN101983237A (zh) | 2011-03-02 |
| ES2343499B1 (es) | 2011-06-10 |
| EP2236598A4 (en) | 2012-01-25 |
| ES2402183T3 (es) | 2013-04-29 |
| BRPI0819533B1 (pt) | 2018-06-05 |
| ES2343499A1 (es) | 2010-08-02 |
| CN101983237B (zh) | 2013-06-12 |
| EP2236598B1 (en) | 2012-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI2236598T1 (sl) | Mikroorganizmi za izboljšanje zdravja posameznikov z motnjami, ki se nanašajo na uživanje glutena | |
| ZA201000246B (en) | Improvements relating to the fitting of spectacles | |
| IL195906A0 (en) | Alpha-aminoamide derivatives useful in the treatment of cognitive disorders | |
| IL204886A0 (en) | Methods of treating gastrointestinal disorders independent of the intake of food | |
| AU2008233088A8 (en) | Calcimimetic compounds for use in the treatment of bowel disorders | |
| GB0902537D0 (en) | Improvememts in or relating to the creation of curved forms | |
| PL385440A1 (pl) | Sposób wytwarzania 4'-O- -D-glukozylo-2',4-dihydroksy-6'-metoksy-3'-prenylochalkonu | |
| ZA201108106B (en) | Use of phthalimide derivatives in the treatment of diseases | |
| IL207647A0 (en) | Use of interleukin-1 conjugates in the treatment of diabetes | |
| WO2010085799A9 (en) | Compositions and method for the treatment of parkinson's disease | |
| EP2225559B8 (en) | Assessment of physiological conditions | |
| GB0720400D0 (en) | Improvements in or relating to the preparation of beverages | |
| GB0902538D0 (en) | Improvvements in or relating to the creation of curved forms | |
| IL206128A0 (en) | Use of 4-oxobutanoic acid derivatives in the treatment of pathologies associated with immunological disorders | |
| PL383170A1 (pl) | Sposób otrzymywania preparatu wapniowego | |
| GB0814043D0 (en) | The treatment of skin disorders | |
| GB2432276B (en) | Connecting to the internet | |
| HK1146216A (en) | Use of interleukin-1 conjugates in the treatment of diabetes | |
| PL379558A1 (pl) | Sposób otrzymywania preparatu enzymów | |
| PL379557A1 (pl) | Sposób otrzymywania preparatu enzymów | |
| AU2008904643A0 (en) | Joint and arthritis health formula | |
| GB0711369D0 (en) | Improvements to the measurement of daily activity | |
| GB0720032D0 (en) | Improvements relating to the entrapment of fine particulates | |
| AU2007900485A0 (en) | Indentifying Persons Susceptible to Pathological Myopia | |
| AU2008903823A0 (en) | Health Supplement Compositions |